While biotech headlines chase CRISPR and AI drug discovery, Formulatrix operates in the critical, unglamorous foundation of life science: preparing and analyzing proteins and nucleic acids. This isn't a startup chasing hype; it's a mature, high-revenue machine building the literal plumbing of modern biology.

"Formulatrix doesn't sell software; they sell the automation that makes the science possible. Their traffic isn't viral—it's loyal."

The tech stack—jQuery, Tailwind, Bootstrap—is pragmatic, not flashy. It’s built for utility and speed, not to win design awards. The lack of Trustpilot reviews is telling: this isn't a B2C product. Their customers don't leave reviews on public sites; they sign multi-year enterprise contracts. The CEO, Jeremy Stevenson, leads a company that has likely scaled through direct sales and deep technical partnerships, not viral marketing.

• Revenue-per-employee of ~$155k indicates high-value, complex sales cycles.
• Direct traffic dominance (48%) signals a captive, professional user base.
• The 'npm ci' keyword proves they're crossing into software and bioinformatics, not just hardware.